Aggravated Gut Microbiota and Metabolomic Imbalances Are Associated with Hypertension Patients Comorbid with Atrial Fibrillation.

Disordered gut microbiota (GM) as the co-contributor of atrial fibrillation (AF) and hypertension (HTN) might be associated with AF risk in HTN. This study aimed to explore the altered GM community and metabolic patterns between 27 HTN patients with AF (HTN-AF) and 27 non-AF HTN patients through fecal metagenomic and serum metabolomic analysis. Compared to non-AF HTN patients, significant microbial alterations (<i>p</i> = 0.004), including increased microbial diversity (<i>p</i> &amp;lt; 0.05), shifted enterotype dominated by <i>Prevotella</i> to <i>Bacteroides</i>, and abundant disease-linked genera <i>Ruminococcus</i>, <i>Streptococcus</i>, <i>Veillonella</i>, <i>Dorea</i>, and <i>Enterococcus</i>, were observed in HTN-AF patients. A species-based random forest prediction model was associated with the risk of AF occurrence in HTN patients. Furthermore, GM metabolic profiles dramatically differed between HTN and HTN-AF patients, especially the imbalance of saturated and unsaturated fatty acids. In HTN-AF patients, circulating palmitic acid and arachidonic acid levels were significantly elevated, while the levels of tetracosahexaenoic acid, oleic acid, linoleic acid, and stearic acid were decreased (<i>p</i> &amp;lt; 0.001, VIP &amp;gt; 1), mediating 85.99% of gut microbial indirect effects on AF (<i>p</i> &amp;lt; 0.001). Thus, our findings preliminarily indicated that exacerbated dysbiosis of GM and relevant metabolites was associated with high AF susceptibility and might be a potential target for AF prediction and prevention in HTN.